MedTrace Logo

Morning Light Treatment for Traumatic Stress: The Role of Amygdala Reactivity

NCT04117347 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-12-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effect of different amounts of time of morning light on brain emotional processing.

Conditions

  • Stress

Interventions

DEVICE

Light therapy A via the Re-Timer®

Subjects will conduct light treatment in the mornings at home.

DEVICE

Light therapy B via the Re-Timer®

Subjects will conduct light treatment in the mornings at home.

DEVICE

Light therapy C via the Re-Timer®

Subjects will conduct light treatment in the mornings at home.

Sponsors & Collaborators

Principal Investigators

  • Helen Burgess · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-24
Primary Completion
2023-03-08
Completion
2023-03-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04117347 on ClinicalTrials.gov